Diversified Trust
MRNA icon

Diversified Trust’s Moderna MRNA Stock Holding History

Diversified Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810K Buy
+4,204
New +$453K 0.02% 528
2025
Q4 		– Sell
-19,187
Closed -$496K – 1080
2025
Q3 		$496K Sell
19,187
-1,757
-8% -$49K 0.01% 638
2025
Q2 		$578K Buy
20,944
+7,300
+54% +$192K 0.01% 556
2025
Q1 		$387K Buy
+13,644
New +$484K 0.01% 647
2024
Q1 		– Sell
-4,487
Closed -$446K – 898
2023
Q4 		$446K Buy
+4,487
New +$377K 0.02% 533
2023
Q2 		– Sell
-2,343
Closed -$360K – 881
2023
Q1 		$360K Sell
2,343
-103
-4% -$17K 0.01% 570
2022
Q4 		$439K Sell
2,446
-439
-15% -$71.8K 0.02% 463
2022
Q3 		$341K Buy
2,885
+153
+6% +$23.2K 0.02% 502
2022
Q2 		$390K Sell
2,732
-157
-5% -$22.4K 0.02% 476
2022
Q1 		$498K Buy
2,889
+137
+5% +$23.1K 0.02% 451
2021
Q4 		$699K Sell
2,752
-16
-0.6% -$4.68K 0.02% 350
2021
Q3 		$1.06M Buy
2,768
+391
+16% +$144K 0.04% 214
2021
Q2 		$559K Sell
2,377
-51
-2% -$9.11K 0.02% 364
2021
Q1 		$318K Buy
2,428
+456
+23% +$66.1K 0.01% 517
2020
Q4 		$206K Buy
+1,972
New +$200K 0.01% 663

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Diversified Trust's MRNA Position: Q3 2026 in Review

Diversified Trust opened a new position in Moderna (MRNA) in Q3 2026: 4,204 shares worth $810K. The stake represents 0.02% of the portfolio and ranks #528 among its holdings. This is a return to the name: Diversified Trust previously reported a position in MRNA as recently as Q3 2025.

Diversified Trust first reported a position in MRNA in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.06M in Q3 2021. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Diversified Trust held 4,204 shares of Moderna worth $810K as of Q3 2026.
  • Moderna was a new Diversified Trust position in Q3 2026.
  • Moderna made up 0.02% of Diversified Trust's portfolio in Q3 2026, its #528 holding.
  • Diversified Trust first reported a position in Moderna in Q4 2020 and has held it in 15 quarters since.
  • Diversified Trust's Moderna position peaked at $1.06M in Q3 2021.
  • 633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.